 | | COMPOUND: C07897 | |
| Entry |
|
|---|
| Name |
|
|---|
| Remark |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 IMMUNOSUPPRESSANTS
L04A IMMUNOSUPPRESSANTS
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB01 Etanercept
D00742 Etanercept (USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Immunological Agents
Immunosuppressants
Tumor Necrosis Factor (TNF) Blockers
Etanercept
D00742 Etanercept (USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
399 Miscellaneous
3999 Others
D00742 Etanercept (USAN/INN); Etanercept (genetical recombination) (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 1] (JAN); Etanercept (genetical recombination) [Etanercept biosimilar 2] (JAN)
Drug groups [BR:br08330]
Anti-inflammatory
DG01985 Disease modifying anti-rheumatic drug (DMARD)
DG01936 TNF inhibitor
D00742 Etanercept
Drug classes [BR:br08332]
Immunological agent
DG01936 TNF inhibitor
D00742 Etanercept
Antirheumatic agent
DG01985 Disease modifying anti-rheumatic drug (DMARD)
D00742 Etanercept
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokines
Tumor necrosis factors
TNF (TNFA, TNFSF2)
D00742 Etanercept (USAN/INN) <JP/US>
LTA (TNFB, TNFSF1)
D00742 Etanercept (USAN/INN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00742
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00742
|
|---|
| Other DBs |
|
|---|
|
» Japanese version
|
|